Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

A new study shows that coffee is among the most commonly used "natural health products" used by people with Parkinson's ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...